“…PBM, previously known as low-level laser (light) therapy (LLLT), uses visible and near-infrared light with a wavelength from 450 to 1100 nm to trigger photochemical changes within intracellular cellular structures. PBM has been used clinically for more than 50 years and studied in various diseases and conditions, such as muscle [ 5 ], wound healing [ 6 ], pain relief [ 7 ], arthritis [ 8 ], hair loss [ 9 ], orthodontic mini-implant stability [ 10 ], neurodegenerative diseases [ 11 ] and most recently in COVID-19 patients [ 12 ]. PBM has been shown over decades to be a patient-directed, adjunctive, effective, non-invasive, and safe treatment option to mitigate mitochondrial dysfunction [ 13 ], oxidative stress [ 14 , 15 ], inflammatory conditions [ 16 ], and, more recently, gut microbiota dysbiosis [ 17 ], which are all primary contributors to CKD.…”